World Alzheimer's Day 2021: The Power of Knowledge

World Alzheimer's Day is an international campaign organised by Alzheimer's Disease International to raise awareness and highlight issues faced by people affected by dementia. It takes place every year on September 21st and is the focus of World Alzheimer's Month.

Dementia is one of the biggest challenges we face, with nearly 50 million people living with dementia worldwide. Yet 2 out of every 3 people globally believe there is little or no understanding of dementia in their countries.The impact of World Alzheimer's Month is growing, but the stigmatisation and misinformation that surrounds dementia remains a global problem. To tackle this challenge, we need to collaborate and share best practice with one another.

In support of this year’s theme – ‘Know dementia, know Alzheimer's’ - Elsevier presents a curated, open access collection of over 70 journal articles and book chapters focused on shining a light on the warning signs of dementia and the importance of a timely diagnosis.

Elsevier,

Neurochemistry International, Volume 147, July 2021

Current knowledge of grape derived polyphenol in Alzheimer's disease research.
Elsevier,

Clinical Simulation in Nursing, Volume 55, June 2021

Virtual reality training programs offer health providers an opportunity to understand the isolated, fragmented and confusing world of persons with dementia. Research indicates that providers who are more empathetic provide better care and increase patient satisfaction and clinical outcomes.
Elsevier,

She Ji, Volume 7, Summer 2021

This article indicates that social systems are already continually influenced by actors through their everyday activities. When the need for more intentional intervention in this ongoing systems evolution arises, social structures are a key leverage point for catalyzing systemic change.
Elsevier,

Heliyon, Volume 7, June 2021

This study aimed to optimise feature selection to improve classification accuracy of various stages in Alzheimer's disease progression.
Elsevier,

Public Health, Volume 194, May 2021

Research on how online singing communities during the COVID-19 pandemic can be beneficial to people living with dementia.
Elsevier,

Progress in Retinal and Eye Research, Volume 82, May 2021

Amyloid β and tau protein changes occur in the retina in Alzheimer's Disease pathophysiology. Ability to monitor retinal molecular changes in conjunction with clinical examination could improve disease diagnosis.
Elsevier,

Behavioural Brain Research, Volume 402, 26 March 2021

Melatonin improved recognition, memory and passive avoidance performance deficits in AD mouse model. Resveratrol improved passive avoidance memory deficit in AD mouse model.
Elsevier,

Biomedical Signal Processing and Control, Volume 65, March 2021

This article investigates using Hjorth parameters in early detection of Alzheimer's disease contributing to SDG3: Good health and well-being.
Elsevier,

Heliyon, Volume 7, February 2021

This study evaluated the neuroprotective effect of Indian Catechu methanolic extract (ICME) in a rat model of AD using Aluminum Chloride (AlCl3). The results showed that ICME could have a positive impact on the course of AD through its anticholinesterase effect and significant antioxidant effect which was reflected on the animals both on behavioral tests as well as hallmark pathological findings.
Elsevier,

Measurement: Journal of the International Measurement Confederation, Volume 171, February 2021

Examining a Computer-Aided Diagnosis (CAD) system to detect and classify Alzheimer Disease on MRI real image, advancing SDG3: Good health and well-being.